Featured Research

from universities, journals, and other organizations

South American Frog Secretions Stimulate Insulin Release, Could Offer Diabetes Treatment Hope

Date:
March 5, 2008
Source:
University of Ulster
Summary:
Secretions from the skin of a South American frog could provide a new treatment for diabetes. The paradoxical frog, Pseudis paradoxa, secretes a substance from its skin which protects it from infection. But the molecule, pseudin-2, may have another use for humans. Researchers found that it stimulates the release of insulin, the vital hormone which is deficient in diabetes sufferers.

Biomedical scientist Dr Yasser Abdel-Wahab has discovered that secretions from the skin of a South American frog could provide a new treatment for diabetes.
Credit: Image courtesy of University of Ulster

Secretions from the skin of a South American frog could provide a new treatment for diabetes, says a University of Ulster scientist.

The paradoxical frog, Pseudis paradoxa, secretes a substance from its skin which protects it from infection. But the molecule, pseudin-2, may have another use for humans. Researchers found that it stimulates the release of insulin, the vital hormone which is deficient in diabetes sufferers.

Scientists made an artificial copy of the peptide, or protein building block, and showed that it could be used to boost insulin production in people with Type 2 diabetes.

They believe it could provide a new diabetes drug treatment, part of a new class of medicines called incretin mimetics which mimic natural substances.

However more work must be carried out before the frog therapy is ready to be tested on human patients.

The work is being carried out by researchers at the University of Ulster and United Arab Emirates University. Dr Yasser Abdel-Wahab, senior lecturer in biomedical sciences at the University of Ulster, says: "We are at an exciting stage with this research. "We have tested a more potent synthetic version of the pseudin-2 peptide and have found that it has the potential for development into a compound for the treatment of Type 2 diabetes.

"Now we need to take this a step further and put our work into practice to try and help people with Type 2 diabetes.

"More research is needed, but there is a growing body of work around natural anti-diabetic drug discovery that, as you can see, is already yielding fascinating results."

Insulin is essential for controlling the way the body fuels itself with sugar. Normally insulin is produced by cells in the pancreas in the right amounts needed to regulate blood sugar levels. But in Type 2 diabetes either not enough is produced, or the body becomes resistant to the concentrations that are available.

The Type 2 version of the disease is strongly associated with obesity and usually develops in middle age. Type 1, or insulin-dependent diabetes, is a less common autoimmune disease that results in the complete destruction of insulin-producing cells.

Currently there are 2.3 million diagnosed diabetes sufferers in the UK,most of whom have Type 2 diabetes. An estimated 750,000 people have Type2 diabetes but do not know it.

The frog research was presented March 3 at the Diabetes UK Annual Professional Conference in Glasgow.

Douglas Smallwood, chief executive of the Diabetes UK charity, says, "Although it can be managed with diet and physical activity, Type 2 diabetes is progressive and may require tablets and/or insulin to control it effectively. Good diabetes control reduces the risk of complications including blindness, heart disease, kidney problems and amputation so new treatments are vital."

The bright green and pink paradoxical frog, from Trinidad and the Amazon basin, is appropriately named because of its odd habit of shrinking with age.

As a tadpole, it can reach 27 centimetres in length, but adult frogs are only about four centimetres long.


Story Source:

The above story is based on materials provided by University of Ulster. Note: Materials may be edited for content and length.


Cite This Page:

University of Ulster. "South American Frog Secretions Stimulate Insulin Release, Could Offer Diabetes Treatment Hope." ScienceDaily. ScienceDaily, 5 March 2008. <www.sciencedaily.com/releases/2008/03/080304224051.htm>.
University of Ulster. (2008, March 5). South American Frog Secretions Stimulate Insulin Release, Could Offer Diabetes Treatment Hope. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2008/03/080304224051.htm
University of Ulster. "South American Frog Secretions Stimulate Insulin Release, Could Offer Diabetes Treatment Hope." ScienceDaily. www.sciencedaily.com/releases/2008/03/080304224051.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins